Research & Publications
A career in cardiovascular research and academic medicine.
Dr. Marmur’s clinical perspective has been informed by decades of cardiovascular research, publication, teaching and academic work.
Research Overview
01
Original Research
Clinical investigation in cardiovascular medicine and intervention.
02
Review Articles
Scholarly synthesis of relevant clinical evidence.
03
Case Reports
Clinical observations documented within the publication record.
04
Book Chapters
Academic contributions to medical reference works.
Publication Library
Browse the publication record.
All
Original Articles
Review Articles
Case Reports
Book Chapters
Publication Collection
Category · Year · Authors · Journal · DOI · PDF · External URL
1992
PDGF-responsive gene expression after vascular injury
Induction of PDGF-Responsive Genes in Vascular Smooth Muscle: Implications for the Early Response to Vessel Injury
Marmur JD, Poon M, Rossikhina M, Taubman MB
Circulation
1992
Vascular injury, smooth muscle cells, PDGF, inflammation, gene expression
JE mRNA Accumulates Rapidly in Aortic Injury and in Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cells
Mark B. Taubman; Barrett J. Rollins; Michael Poon; Jonathan Marmur; Robert S. Green; Bradford C. Berk; Bernardo Nadal-Ginard
Circulation Research
1993
Tissue factor induction following arterial balloon injury
Tissue Factor Is Rapidly Induced in Arterial Smooth Muscle After Balloon Injury
Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB
The Journal of Clinical Investigation
1993
Regulation of tissue factor expression in vascular smooth muscle cells
Agonist-Mediated Tissue Factor Expression in Cultured Vascular Smooth Muscle Cells: Role of Ca2+ Mobilization and Protein Kinase C Activation
Taubman MB, Marmur JD, Rosenfield CL, Guha A, Nichtberger S, Nemerson Y
The Journal of Clinical Investigation
1994
Local thrombin generation after balloon angioplasty
Thrombin Generation in Human Coronary Arteries After Percutaneous Transluminal Balloon Angioplasty
Marmur JD, Merlini PA, Sharma SK, Khaghan N, Israel DH, Torre SR, Ardissino D, Ambrose JA
Journal of the American College of Cardiology
1994
Adjunctive urokinase during angioplasty for ischemic rest angina
Adjunctive Thrombolytic Therapy During Angioplasty for Ischemic Rest Angina: Results of the TAUSA Trial
Ambrose JA, Almeida OD, Sharma SK, Torre SR, Marmur JD, Israel DH, Ratner DE, Weiss MB, Monsen CE, Myler RK, Moses J, Unterecker WJ, Grunwald AM, Garrett JS, Cowley MJ, Anwar A, Sobolski J
1996
Active tissue factor in human coronary atherosclerotic plaque
The Identification of Active Tissue Factor in Human Coronary Atheroma
Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB
Circulation
1997
Tissue factor, atherosclerosis, thrombosis, plaque rupture, vascular injury
Tissue Factor in the Pathogenesis of Atherosclerosis
Mark B. Taubman; John T. Fallon; Alison D. Schecter; Peter Giesen; Milton Medowitz; Billie S. Fyfe; Jonathan D. Marmur; Yale Nemerson
Thrombosis and Haemostasis
1998
Platelet activation during rotational atherectomy
Activation of Platelets in Platelet-Rich Plasma by Rotablation Is Speed-Dependent and Can Be Inhibited by Abciximab (c7E3 Fab; ReoPro)
Williams MS, Coller BS, Vaananen HJ, Scudder LE, Sharma SK, Marmur JD
Circulation
1999
Tirofiban-associated coronary thrombolysis
Tirofiban-Induced Coronary Thrombolysis
Jayasundera TG, Feldman DN, Marmur JD
Journal of Invasive Cardiology
1999
CK-MB elevation and outcomes after coronary intervention
Creatine Kinase-MB Elevation After Coronary Intervention Correlates With Diffuse Atherosclerosis, and Low-to-Medium Level Elevation Has a Benign Clinical Course: Implications for Early Discharge After Coronary Intervention
Kini A, Marmur JD, Kini S, Dangas G, Cocke TP, Wallenstein S, Brown E, Ambrose JA, Sharma SK
Journal of the American College of Cardiology
2000
Beta-blocker therapy and myocardial injury after coronary intervention
Cardioprotective Effect of Prior Beta-Blocker Therapy in Reducing Creatine Kinase-MB Elevation After Coronary Intervention: Benefit Is Extended to Improvement in Intermediate-Term Survival
Sharma SK, Kini A, Marmur JD, Fuster V
Circulation
2000
Abciximab effects on arterial thrombus formation
Antithrombotic Effects of Abciximab
Hayes R, Chesebro JH, Fuster V, Dangas G, Fallon JT, Sharma SK, Coller BS, Badimon L, Marmur JD, Badimon JJ
American Journal of Cardiology
2000
Angiographic patterns and treatment of in-stent restenosis
Angiographic Patterns of In-Stent Restenosis and Implications on Subsequent Revascularization
Kini A, Marmur JD, Dangas G, Choudhary S, Sharma SK
Catheterization and Cardiovascular Interventions
2002
Ribozyme-mediated inhibition of tissue factor expression
Inhibition of Tissue Factor Gene Induction and Activity Using a Hairpin Ribozyme
Cavusoglu E, Chen I, Rappaport J, Marmur JD
Circulation
2002
Tissue factor and tissue factor pathway inhibitor in intravascular thrombosis
Evolving Role of Tissue Factor and Its Pathway Inhibitor
Doshi SN, Marmur JD
Critical Care Medicine
2002
Comparison of GP IIb/IIIa inhibitors during PCI
Effectiveness of Tirofiban, Eptifibatide, and Abciximab in Minimizing Myocardial Necrosis During Percutaneous Coronary Intervention (TEAM Pilot Study)
Kini AS, Richard M, Suleman J, Perez N, Lee P, Fisher EA, Kamran M, Marmur JD, Sharma SK
American Journal of Cardiology
2002
Comparison of heparin-based and direct thrombin inhibition strategies in PCI
Direct Versus Indirect Thrombin Inhibition in Percutaneous Coronary Intervention
Marmur JD
Journal of Invasive Cardiology
2002
Tissue factor inhibition with inactivated factor VIIa during PCI
Antithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIa: An Ex Vivo Human Study
Lev EI, Marmur JD, Zdravkovic M, Osende JI, Robbins J, Delfin JA, Richard M, Erhardtsen E, Thomsen MS, Lincoff AM, Badimon JJ
Arteriosclerosis, Thrombosis, and Vascular Biology
2002
FGF4 gene therapy for chronic stable angina
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur JD, West A, Rade JJ, Marrott P, Hammond HK, Engler RL
Circulation
2003
Activated clotting time monitoring of intravenous dalteparin during PCI
The Activated Clotting Time Can Be Used to Monitor the Low Molecular Weight Heparin Dalteparin After Intravenous Administration
Marmur JD, Anand SX, Bagga RS, Fareed J, Pan CM, Sharma SK, Richard MF
Journal of the American College of Cardiology
2003
CD40 ligand signaling in atherothrombosis
Membrane-Associated CD40L and sCD40L in Atherothrombotic Disease
Anand SX, Viles-Gonzalez JF, Badimon JJ, Cavusoglu E, Marmur JD
Thrombosis and Haemostasis
2004
Rotational atherectomy technique, indications, and outcomes
Current Status of Rotational Atherectomy
Cavusoglu E, Kini AS, Marmur JD, Sharma SK
Catheterization and Cardiovascular Interventions
2005
Direct thrombin inhibitors during PCI
Direct Thrombin Inhibitor Use During Percutaneous Coronary Intervention
Kokolis S, Clark LT, Cavusoglu E, Marmur JD
Journal of Cardiovascular Pharmacology
2006
TIMP-1 as a prognostic biomarker in coronary artery disease
Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Is an Independent Predictor of All-Cause Mortality, Cardiac Mortality, and Myocardial Infarction
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD
American Heart Journal
2006
Low-molecular-weight heparin dosing and monitoring during PCI
Strategies for the Safe and Rational Use of Dalteparin or Enoxaparin During Percutaneous Coronary Intervention
Marmur JD, Bullock-Palmer RP, Lakhani MJ, Cavusoglu E
Journal of Invasive Cardiology
2006
ACT-guided low-molecular-weight heparin use in the catheterization laboratory
Lessons Learned From the Use of Low-Molecular-Weight Heparin in the Cardiac Catheterization Laboratory — A Series of Case Reports
Bullock-Palmer RP, Lakhani MJ, Marmur JD
Journal of Invasive Cardiology
2006
Bolus-only GP IIb/IIIa inhibitor strategy during PCI
Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention
Marmur JD, Poludasu S, Agarwal A, Vladutiu P, Feit A, Lapin R, Cavusoglu E
Journal of Invasive Cardiology
2006
Bolus-only glycoprotein IIb/IIIa inhibition during PCI
Benefit of Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention: Insights From the Very Early Outcomes in the EPIC Trial
Marmur JD, Mitre CA, Barnathan E, Cavusoglu E
American Heart Journal
2006
Adiponectin as a prognostic cardiovascular biomarker
Adiponectin Is an Independent Predictor of All-Cause Mortality, Cardiac Mortality, and Myocardial Infarction in Patients Presenting With Chest Pain
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD
European Heart Journal
2007
F11R/JAM-A expression in atherosclerotic plaques and inflammatory thrombosis
The F11 Receptor (F11R/JAM-A) in Atherothrombosis: Overexpression of F11R in Atherosclerotic Plaques
Babinska A, Azari BM, Salifu MO, Liu R, Jiang XC, Sobocka MB, Boo D, Al Khoury G, Deitch JS, Marmur JD, Ehrlich YH, Kornecki E
Thrombosis and Haemostasis
2007
Inflammation, chemokines, RANTES, coronary artery disease, cardiovascular risk prediction
Low Plasma RANTES Levels Are an Independent Predictor of Cardiac Mortality in Patients Referred for Coronary Angiography
Erdal Cavusoglu; Calvin Eng; Vineet Chopra; Luther T. Clark; David J. Pinsky; Jonathan D. Marmur
Arteriosclerosis, Thrombosis, and Vascular Biology
2010
Red blood cell distribution width as a mortality biomarker
Relation Between Red Blood Cell Distribution Width (RDW) and All-Cause Mortality at Two Years in an Unselected Population Referred for Coronary Angiography
Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD
International Journal of Cardiology
2016
Dual antiplatelet therapy duration after drug-eluting stent implantation
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome: A Systematic Review of Randomized Controlled Trials
Sharma A, Lavie CJ, Sharma SK, Garg A, Vallakati A, Mukherjee D, Marmur JD
Mayo Clinic Proceedings
Research Themes
Recurring areas of cardiovascular inquiry.
01
Coronary Intervention
02
Atherosclerosis
03
Antithrombotic Therapy
04
Cardiovascular Outcomes
05
Vascular Biology
Book Chapters
Academic contributions beyond journal publication.
Academic Reference Work
Book chapter details, including chapter title, editors, publisher and publication year, are retained in the complete academic CV.
Academic Activity
Selected Invited Lectures
+
Academic Record
Complete Academic Curriculum Vitae
The full CV contains appointments, certifications, research, publications, lectures and professional history.
Clinical Care
Clinical experience informed by academic inquiry.
© 2026 Jonathan D. Marmur, MD. All rights reserved.
Privacy
Accessibility
Terms
Research & Publications
A career in cardiovascular research and academic medicine.
Dr. Marmur’s clinical perspective has been informed by decades of cardiovascular research, publication, teaching and academic work.
Research Overview
01
Original Research
Clinical investigation in cardiovascular medicine and intervention.
02
Review Articles
Scholarly synthesis of relevant clinical evidence.
03
Case Reports
Clinical observations documented within the publication record.
04
Book Chapters
Academic contributions to medical reference works.
Publication Library
All
Original Articles
Review Articles
Case Reports
Book Chapters
Browse the publication record.
Publication Collection
Category · Year · Authors · Journal · DOI · PDF · External URL
1992
PDGF-responsive gene expression after vascular injury
Induction of PDGF-Responsive Genes in Vascular Smooth Muscle: Implications for the Early Response to Vessel Injury
Marmur JD, Poon M, Rossikhina M, Taubman MB
Circulation
1992
Vascular injury, smooth muscle cells, PDGF, inflammation, gene expression
JE mRNA Accumulates Rapidly in Aortic Injury and in Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cells
Mark B. Taubman; Barrett J. Rollins; Michael Poon; Jonathan Marmur; Robert S. Green; Bradford C. Berk; Bernardo Nadal-Ginard
Circulation Research
1993
Tissue factor induction following arterial balloon injury
Tissue Factor Is Rapidly Induced in Arterial Smooth Muscle After Balloon Injury
Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB
The Journal of Clinical Investigation
1993
Regulation of tissue factor expression in vascular smooth muscle cells
Agonist-Mediated Tissue Factor Expression in Cultured Vascular Smooth Muscle Cells: Role of Ca2+ Mobilization and Protein Kinase C Activation
Taubman MB, Marmur JD, Rosenfield CL, Guha A, Nichtberger S, Nemerson Y
The Journal of Clinical Investigation
1994
Local thrombin generation after balloon angioplasty
Thrombin Generation in Human Coronary Arteries After Percutaneous Transluminal Balloon Angioplasty
Marmur JD, Merlini PA, Sharma SK, Khaghan N, Israel DH, Torre SR, Ardissino D, Ambrose JA
Journal of the American College of Cardiology
1994
Adjunctive urokinase during angioplasty for ischemic rest angina
Adjunctive Thrombolytic Therapy During Angioplasty for Ischemic Rest Angina: Results of the TAUSA Trial
Ambrose JA, Almeida OD, Sharma SK, Torre SR, Marmur JD, Israel DH, Ratner DE, Weiss MB, Monsen CE, Myler RK, Moses J, Unterecker WJ, Grunwald AM, Garrett JS, Cowley MJ, Anwar A, Sobolski J
1996
Active tissue factor in human coronary atherosclerotic plaque
The Identification of Active Tissue Factor in Human Coronary Atheroma
Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB
Circulation
1997
Tissue factor, atherosclerosis, thrombosis, plaque rupture, vascular injury
Tissue Factor in the Pathogenesis of Atherosclerosis
Mark B. Taubman; John T. Fallon; Alison D. Schecter; Peter Giesen; Milton Medowitz; Billie S. Fyfe; Jonathan D. Marmur; Yale Nemerson
Thrombosis and Haemostasis
1998
Platelet activation during rotational atherectomy
Activation of Platelets in Platelet-Rich Plasma by Rotablation Is Speed-Dependent and Can Be Inhibited by Abciximab (c7E3 Fab; ReoPro)
Williams MS, Coller BS, Vaananen HJ, Scudder LE, Sharma SK, Marmur JD
Circulation
1999
Tirofiban-associated coronary thrombolysis
Tirofiban-Induced Coronary Thrombolysis
Jayasundera TG, Feldman DN, Marmur JD
Journal of Invasive Cardiology
1999
CK-MB elevation and outcomes after coronary intervention
Creatine Kinase-MB Elevation After Coronary Intervention Correlates With Diffuse Atherosclerosis, and Low-to-Medium Level Elevation Has a Benign Clinical Course: Implications for Early Discharge After Coronary Intervention
Kini A, Marmur JD, Kini S, Dangas G, Cocke TP, Wallenstein S, Brown E, Ambrose JA, Sharma SK
Journal of the American College of Cardiology
2000
Beta-blocker therapy and myocardial injury after coronary intervention
Cardioprotective Effect of Prior Beta-Blocker Therapy in Reducing Creatine Kinase-MB Elevation After Coronary Intervention: Benefit Is Extended to Improvement in Intermediate-Term Survival
Sharma SK, Kini A, Marmur JD, Fuster V
Circulation
2000
Abciximab effects on arterial thrombus formation
Antithrombotic Effects of Abciximab
Hayes R, Chesebro JH, Fuster V, Dangas G, Fallon JT, Sharma SK, Coller BS, Badimon L, Marmur JD, Badimon JJ
American Journal of Cardiology
2000
Angiographic patterns and treatment of in-stent restenosis
Angiographic Patterns of In-Stent Restenosis and Implications on Subsequent Revascularization
Kini A, Marmur JD, Dangas G, Choudhary S, Sharma SK
Catheterization and Cardiovascular Interventions
2002
Ribozyme-mediated inhibition of tissue factor expression
Inhibition of Tissue Factor Gene Induction and Activity Using a Hairpin Ribozyme
Cavusoglu E, Chen I, Rappaport J, Marmur JD
Circulation
2002
Tissue factor and tissue factor pathway inhibitor in intravascular thrombosis
Evolving Role of Tissue Factor and Its Pathway Inhibitor
Doshi SN, Marmur JD
Critical Care Medicine
2002
Comparison of GP IIb/IIIa inhibitors during PCI
Effectiveness of Tirofiban, Eptifibatide, and Abciximab in Minimizing Myocardial Necrosis During Percutaneous Coronary Intervention (TEAM Pilot Study)
Kini AS, Richard M, Suleman J, Perez N, Lee P, Fisher EA, Kamran M, Marmur JD, Sharma SK
American Journal of Cardiology
2002
Comparison of heparin-based and direct thrombin inhibition strategies in PCI
Direct Versus Indirect Thrombin Inhibition in Percutaneous Coronary Intervention
Marmur JD
Journal of Invasive Cardiology
2002
Tissue factor inhibition with inactivated factor VIIa during PCI
Antithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIa: An Ex Vivo Human Study
Lev EI, Marmur JD, Zdravkovic M, Osende JI, Robbins J, Delfin JA, Richard M, Erhardtsen E, Thomsen MS, Lincoff AM, Badimon JJ
Arteriosclerosis, Thrombosis, and Vascular Biology
2002
FGF4 gene therapy for chronic stable angina
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur JD, West A, Rade JJ, Marrott P, Hammond HK, Engler RL
Circulation
2003
Activated clotting time monitoring of intravenous dalteparin during PCI
The Activated Clotting Time Can Be Used to Monitor the Low Molecular Weight Heparin Dalteparin After Intravenous Administration
Marmur JD, Anand SX, Bagga RS, Fareed J, Pan CM, Sharma SK, Richard MF
Journal of the American College of Cardiology
2003
CD40 ligand signaling in atherothrombosis
Membrane-Associated CD40L and sCD40L in Atherothrombotic Disease
Anand SX, Viles-Gonzalez JF, Badimon JJ, Cavusoglu E, Marmur JD
Thrombosis and Haemostasis
2004
Rotational atherectomy technique, indications, and outcomes
Current Status of Rotational Atherectomy
Cavusoglu E, Kini AS, Marmur JD, Sharma SK
Catheterization and Cardiovascular Interventions
2005
Direct thrombin inhibitors during PCI
Direct Thrombin Inhibitor Use During Percutaneous Coronary Intervention
Kokolis S, Clark LT, Cavusoglu E, Marmur JD
Journal of Cardiovascular Pharmacology
2006
TIMP-1 as a prognostic biomarker in coronary artery disease
Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Is an Independent Predictor of All-Cause Mortality, Cardiac Mortality, and Myocardial Infarction
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD
American Heart Journal
2006
Low-molecular-weight heparin dosing and monitoring during PCI
Strategies for the Safe and Rational Use of Dalteparin or Enoxaparin During Percutaneous Coronary Intervention
Marmur JD, Bullock-Palmer RP, Lakhani MJ, Cavusoglu E
Journal of Invasive Cardiology
2006
ACT-guided low-molecular-weight heparin use in the catheterization laboratory
Lessons Learned From the Use of Low-Molecular-Weight Heparin in the Cardiac Catheterization Laboratory — A Series of Case Reports
Bullock-Palmer RP, Lakhani MJ, Marmur JD
Journal of Invasive Cardiology
2006
Bolus-only GP IIb/IIIa inhibitor strategy during PCI
Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention
Marmur JD, Poludasu S, Agarwal A, Vladutiu P, Feit A, Lapin R, Cavusoglu E
Journal of Invasive Cardiology
2006
Bolus-only glycoprotein IIb/IIIa inhibition during PCI
Benefit of Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention: Insights From the Very Early Outcomes in the EPIC Trial
Marmur JD, Mitre CA, Barnathan E, Cavusoglu E
American Heart Journal
2006
Adiponectin as a prognostic cardiovascular biomarker
Adiponectin Is an Independent Predictor of All-Cause Mortality, Cardiac Mortality, and Myocardial Infarction in Patients Presenting With Chest Pain
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD
European Heart Journal
2007
F11R/JAM-A expression in atherosclerotic plaques and inflammatory thrombosis
The F11 Receptor (F11R/JAM-A) in Atherothrombosis: Overexpression of F11R in Atherosclerotic Plaques
Babinska A, Azari BM, Salifu MO, Liu R, Jiang XC, Sobocka MB, Boo D, Al Khoury G, Deitch JS, Marmur JD, Ehrlich YH, Kornecki E
Thrombosis and Haemostasis
2007
Inflammation, chemokines, RANTES, coronary artery disease, cardiovascular risk prediction
Low Plasma RANTES Levels Are an Independent Predictor of Cardiac Mortality in Patients Referred for Coronary Angiography
Erdal Cavusoglu; Calvin Eng; Vineet Chopra; Luther T. Clark; David J. Pinsky; Jonathan D. Marmur
Arteriosclerosis, Thrombosis, and Vascular Biology
2010
Red blood cell distribution width as a mortality biomarker
Relation Between Red Blood Cell Distribution Width (RDW) and All-Cause Mortality at Two Years in an Unselected Population Referred for Coronary Angiography
Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD
International Journal of Cardiology
2016
Dual antiplatelet therapy duration after drug-eluting stent implantation
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome: A Systematic Review of Randomized Controlled Trials
Sharma A, Lavie CJ, Sharma SK, Garg A, Vallakati A, Mukherjee D, Marmur JD
Mayo Clinic Proceedings
Featured Research
Selected cardiovascular research
Selected work is presented in a journal-style format. Additional bibliographic details are maintained within the full publication collection.
2022
Cardiovascular Outcomes
Impact of New-Onset Versus Pre-Existing Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement / Implantation
Marmur JD, et al.
International Journal of Cardiology: Heart & Vasculature
Research Themes
Recurring areas of cardiovascular inquiry.
01
Coronary Intervention
02
Atherosclerosis
03
Antithrombotic Therapy
04
Cardiovascular Outcomes
05
Vascular Biology
Book Chapters
Academic contributions beyond journal publication.
Academic Reference Work
Book chapter details, including chapter title, editors, publisher and publication year, are retained in the complete academic CV.
Academic Activity
Selected Invited Lectures
+
Academic Record
Complete Academic Curriculum Vitae
The full CV contains appointments, certifications, research, publications, lectures and professional history.
Clinical Care
Clinical experience informed by academic inquiry.
Author
Controlling the Agenda
Amazon ↗
Audible ↗
© 2026 Jonathan D. Marmur, MD. All rights reserved.
Privacy
Accessibility
Terms
Research & Publications
A career in cardiovascular research and academic medicine.
Dr. Marmur’s clinical perspective has been informed by decades of cardiovascular research, publication, teaching and academic work.
Research Overview
01
Original Research
Clinical investigation in cardiovascular medicine and intervention.
02
Review Articles
Scholarly synthesis of relevant clinical evidence.
03
Case Reports
Clinical observations documented within the publication record.
04
Book Chapters
Academic contributions to medical reference works.
Publication Library
Browse the publication record.
All
Original Articles
Review Articles
Case Reports
Book Chapters
1992
PDGF-responsive gene expression after vascular injury
Induction of PDGF-Responsive Genes in Vascular Smooth Muscle: Implications for the Early Response to Vessel Injury
Marmur JD, Poon M, Rossikhina M, Taubman MB
Circulation
1992
Vascular injury, smooth muscle cells, PDGF, inflammation, gene expression
JE mRNA Accumulates Rapidly in Aortic Injury and in Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cells
Mark B. Taubman; Barrett J. Rollins; Michael Poon; Jonathan Marmur; Robert S. Green; Bradford C. Berk; Bernardo Nadal-Ginard
Circulation Research
1993
Tissue factor induction following arterial balloon injury
Tissue Factor Is Rapidly Induced in Arterial Smooth Muscle After Balloon Injury
Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB
The Journal of Clinical Investigation
1993
Regulation of tissue factor expression in vascular smooth muscle cells
Agonist-Mediated Tissue Factor Expression in Cultured Vascular Smooth Muscle Cells: Role of Ca2+ Mobilization and Protein Kinase C Activation
Taubman MB, Marmur JD, Rosenfield CL, Guha A, Nichtberger S, Nemerson Y
The Journal of Clinical Investigation
1994
Local thrombin generation after balloon angioplasty
Thrombin Generation in Human Coronary Arteries After Percutaneous Transluminal Balloon Angioplasty
Marmur JD, Merlini PA, Sharma SK, Khaghan N, Israel DH, Torre SR, Ardissino D, Ambrose JA
Journal of the American College of Cardiology
1994
Adjunctive urokinase during angioplasty for ischemic rest angina
Adjunctive Thrombolytic Therapy During Angioplasty for Ischemic Rest Angina: Results of the TAUSA Trial
Ambrose JA, Almeida OD, Sharma SK, Torre SR, Marmur JD, Israel DH, Ratner DE, Weiss MB, Monsen CE, Myler RK, Moses J, Unterecker WJ, Grunwald AM, Garrett JS, Cowley MJ, Anwar A, Sobolski J
1996
Active tissue factor in human coronary atherosclerotic plaque
The Identification of Active Tissue Factor in Human Coronary Atheroma
Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB
Circulation
1997
Tissue factor, atherosclerosis, thrombosis, plaque rupture, vascular injury
Tissue Factor in the Pathogenesis of Atherosclerosis
Mark B. Taubman; John T. Fallon; Alison D. Schecter; Peter Giesen; Milton Medowitz; Billie S. Fyfe; Jonathan D. Marmur; Yale Nemerson
Thrombosis and Haemostasis
1998
Platelet activation during rotational atherectomy
Activation of Platelets in Platelet-Rich Plasma by Rotablation Is Speed-Dependent and Can Be Inhibited by Abciximab (c7E3 Fab; ReoPro)
Williams MS, Coller BS, Vaananen HJ, Scudder LE, Sharma SK, Marmur JD
Circulation
1999
Tirofiban-associated coronary thrombolysis
Tirofiban-Induced Coronary Thrombolysis
Jayasundera TG, Feldman DN, Marmur JD
Journal of Invasive Cardiology
1999
CK-MB elevation and outcomes after coronary intervention
Creatine Kinase-MB Elevation After Coronary Intervention Correlates With Diffuse Atherosclerosis, and Low-to-Medium Level Elevation Has a Benign Clinical Course: Implications for Early Discharge After Coronary Intervention
Kini A, Marmur JD, Kini S, Dangas G, Cocke TP, Wallenstein S, Brown E, Ambrose JA, Sharma SK
Journal of the American College of Cardiology
2000
Beta-blocker therapy and myocardial injury after coronary intervention
Cardioprotective Effect of Prior Beta-Blocker Therapy in Reducing Creatine Kinase-MB Elevation After Coronary Intervention: Benefit Is Extended to Improvement in Intermediate-Term Survival
Sharma SK, Kini A, Marmur JD, Fuster V
Circulation
2000
Abciximab effects on arterial thrombus formation
Antithrombotic Effects of Abciximab
Hayes R, Chesebro JH, Fuster V, Dangas G, Fallon JT, Sharma SK, Coller BS, Badimon L, Marmur JD, Badimon JJ
American Journal of Cardiology
2000
Angiographic patterns and treatment of in-stent restenosis
Angiographic Patterns of In-Stent Restenosis and Implications on Subsequent Revascularization
Kini A, Marmur JD, Dangas G, Choudhary S, Sharma SK
Catheterization and Cardiovascular Interventions
2002
Ribozyme-mediated inhibition of tissue factor expression
Inhibition of Tissue Factor Gene Induction and Activity Using a Hairpin Ribozyme
Cavusoglu E, Chen I, Rappaport J, Marmur JD
Circulation
2002
Tissue factor and tissue factor pathway inhibitor in intravascular thrombosis
Evolving Role of Tissue Factor and Its Pathway Inhibitor
Doshi SN, Marmur JD
Critical Care Medicine
2002
Comparison of GP IIb/IIIa inhibitors during PCI
Effectiveness of Tirofiban, Eptifibatide, and Abciximab in Minimizing Myocardial Necrosis During Percutaneous Coronary Intervention (TEAM Pilot Study)
Kini AS, Richard M, Suleman J, Perez N, Lee P, Fisher EA, Kamran M, Marmur JD, Sharma SK
American Journal of Cardiology
2002
Comparison of heparin-based and direct thrombin inhibition strategies in PCI
Direct Versus Indirect Thrombin Inhibition in Percutaneous Coronary Intervention
Marmur JD
Journal of Invasive Cardiology
2002
Tissue factor inhibition with inactivated factor VIIa during PCI
Antithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIa: An Ex Vivo Human Study
Lev EI, Marmur JD, Zdravkovic M, Osende JI, Robbins J, Delfin JA, Richard M, Erhardtsen E, Thomsen MS, Lincoff AM, Badimon JJ
Arteriosclerosis, Thrombosis, and Vascular Biology
2002
FGF4 gene therapy for chronic stable angina
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur JD, West A, Rade JJ, Marrott P, Hammond HK, Engler RL
Circulation
2003
Activated clotting time monitoring of intravenous dalteparin during PCI
The Activated Clotting Time Can Be Used to Monitor the Low Molecular Weight Heparin Dalteparin After Intravenous Administration
Marmur JD, Anand SX, Bagga RS, Fareed J, Pan CM, Sharma SK, Richard MF
Journal of the American College of Cardiology
2003
CD40 ligand signaling in atherothrombosis
Membrane-Associated CD40L and sCD40L in Atherothrombotic Disease
Anand SX, Viles-Gonzalez JF, Badimon JJ, Cavusoglu E, Marmur JD
Thrombosis and Haemostasis
2004
Rotational atherectomy technique, indications, and outcomes
Current Status of Rotational Atherectomy
Cavusoglu E, Kini AS, Marmur JD, Sharma SK
Catheterization and Cardiovascular Interventions
2005
Direct thrombin inhibitors during PCI
Direct Thrombin Inhibitor Use During Percutaneous Coronary Intervention
Kokolis S, Clark LT, Cavusoglu E, Marmur JD
Journal of Cardiovascular Pharmacology
2006
TIMP-1 as a prognostic biomarker in coronary artery disease
Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Is an Independent Predictor of All-Cause Mortality, Cardiac Mortality, and Myocardial Infarction
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD
American Heart Journal
2006
Low-molecular-weight heparin dosing and monitoring during PCI
Strategies for the Safe and Rational Use of Dalteparin or Enoxaparin During Percutaneous Coronary Intervention
Marmur JD, Bullock-Palmer RP, Lakhani MJ, Cavusoglu E
Journal of Invasive Cardiology
2006
ACT-guided low-molecular-weight heparin use in the catheterization laboratory
Lessons Learned From the Use of Low-Molecular-Weight Heparin in the Cardiac Catheterization Laboratory — A Series of Case Reports
Bullock-Palmer RP, Lakhani MJ, Marmur JD
Journal of Invasive Cardiology
2006
Bolus-only GP IIb/IIIa inhibitor strategy during PCI
Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention
Marmur JD, Poludasu S, Agarwal A, Vladutiu P, Feit A, Lapin R, Cavusoglu E
Journal of Invasive Cardiology
2006
Bolus-only glycoprotein IIb/IIIa inhibition during PCI
Benefit of Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention: Insights From the Very Early Outcomes in the EPIC Trial
Marmur JD, Mitre CA, Barnathan E, Cavusoglu E
American Heart Journal
2006
Adiponectin as a prognostic cardiovascular biomarker
Adiponectin Is an Independent Predictor of All-Cause Mortality, Cardiac Mortality, and Myocardial Infarction in Patients Presenting With Chest Pain
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD
European Heart Journal
2007
F11R/JAM-A expression in atherosclerotic plaques and inflammatory thrombosis
The F11 Receptor (F11R/JAM-A) in Atherothrombosis: Overexpression of F11R in Atherosclerotic Plaques
Babinska A, Azari BM, Salifu MO, Liu R, Jiang XC, Sobocka MB, Boo D, Al Khoury G, Deitch JS, Marmur JD, Ehrlich YH, Kornecki E
Thrombosis and Haemostasis
2007
Inflammation, chemokines, RANTES, coronary artery disease, cardiovascular risk prediction
Low Plasma RANTES Levels Are an Independent Predictor of Cardiac Mortality in Patients Referred for Coronary Angiography
Erdal Cavusoglu; Calvin Eng; Vineet Chopra; Luther T. Clark; David J. Pinsky; Jonathan D. Marmur
Arteriosclerosis, Thrombosis, and Vascular Biology
2010
Red blood cell distribution width as a mortality biomarker
Relation Between Red Blood Cell Distribution Width (RDW) and All-Cause Mortality at Two Years in an Unselected Population Referred for Coronary Angiography
Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD
International Journal of Cardiology
2016
Dual antiplatelet therapy duration after drug-eluting stent implantation
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome: A Systematic Review of Randomized Controlled Trials
Sharma A, Lavie CJ, Sharma SK, Garg A, Vallakati A, Mukherjee D, Marmur JD
Mayo Clinic Proceedings
Featured Research
Selected cardiovascular research
Selected work is presented in a journal-style format. Additional bibliographic details are maintained within the full publication collection.
2020
Coronary Intervention
A Randomized Evaluation of Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
Marmur JD, et al.
Journal of the American College of Cardiology
Research Themes
Recurring areas of cardiovascular inquiry.
01
Coronary Intervention
02
Atherosclerosis
03
Antithrombotic Therapy
04
Cardiovascular Outcomes
05
Vascular Biology
Book Chapters
Academic contributions beyond journal publication.
Academic Reference Work
Book chapter details, including chapter title, editors, publisher and publication year, are retained in the complete academic CV.
Academic Activity
Selected Invited Lectures
+
Academic Record
Complete Academic Curriculum Vitae
The full CV contains appointments, certifications, research, publications, lectures and professional history.
Clinical Care
Clinical experience informed by academic inquiry.
Author
Controlling the Agenda
Amazon ↗
Audible ↗
© 2026 Jonathan D. Marmur, MD. All rights reserved.
Privacy
Accessibility
Terms